PHAT · ISSUER CIK 1783183
Phathom Pharmaceuticals, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Phathom Pharmaceuticals, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 202617:44 | Oct 6, 2026 | PHAT | Chief Financial & Bus. Officer | F · Tax | $6.78 | −13,485 | 214,718 | -6% | $91K | ||
| Sep 8, 202616:30 | Sep 3, 2026 | PHAT | Principal Accounting Officer | F · TaxLate 5d | $9.05 | −460 | 59,465 | -1% | $4K |